Genomind® Reaches Milestone, Expands Headquarters to Meet Demand
Genomind announced a headquarters expansion and its Genecept Assay® has been used to aid clinicians in treating a total of over 100,000 patients.
Mental Health Month: A Perspective
Genomind President and Chief Executive Officer Michael Koffler shares his thoughts on the importance of Mental Health Month in May.
